The Toxic Science of Flu Vaccines
Joshua Hadfield was a normal, healthy developing child as a toddler. In the midst of the 2010 H1N1 swine flu frenzyand fear mongering about the horrible consequences children face if left unvaccinated, the Hadfield’s had Joshua vaccinated with Glaxo’s Pandermrix influenza vaccine. Within weeks, Joshua could barely wake up, sleeping up to nineteen hours a day. Laughter would trigger seizures.
Joshua was diagnosed with narcolepsy, “an incurable, debilitating condition” associated with acute brain damage. Today we can look back at Pandermrix as a horrible vaccine. Research indicates that it was associated with a 1400% increase in narcolepsy risk. More recently, a team of Finnish scientists at Finland’s National Institute for Health and Welfare, recorded 800 cases of narcolepsy associated with this vaccine. Vaccine ingredients other than the engineered viral antigen are most often believed to be the primary culprits to adverse vaccine reactions. The Finnish research, on the other hand, indicated that the vaccine’s altered viral nucleotide likely contributed to the sudden rise in sleeping sickness.
Although Pandermrix was pulled from the market, it should never have been approved and released in the first place. This is a classic case of regulatory negligence by health officials and the WHO which promulgates flu vaccines around the world. Like all vaccines, which are now commonly fast tracked through government health regulatory bodies for rapid release upon the public, it should have been tested more thoroughly and more rigorously reviewed.
Since the time of Edward Jenner’s primitive inoculation experiments to combat smallpox, and its countless aftermath of deaths throughout the 19th century, modern vaccine science has failed to learn its lessons. The failure of proper regulatory oversight has resulted in Joshua and other British citizens becoming disabled for life. The British government has paid out over 63 million pounds to cover lawsuits to Pandermrix victims. Glaxo has never admitted its flu vaccine caused brain damage. And this begs the question as to why it was withdrawn since it was the corporation’s single flagship vaccine against the swine flu.
We shouldn’t become complacent by assuming flu vaccine risks only affect young children. Sarah Behie was 20 years old after receiving the flu shot. Three weeks later her health deteriorated dramatically. Diagnosed with Guillain-Barre syndrome, a not uncommon adverse effect of influenza vaccination, four years later Sarah remains paralyzed from the waist down, incapable of dressing and feeding herself, and rotting away in hospitals and nursing homes.
Joshua’s and Sarah’s stories are by no means unique. Today tens of thousands of infants, toddlers, children and adults across the nation are increasingly becoming victims of vaccine injuries. No national debate is initiated because regulatory malfeasance within federal health agencies has aligned its self interests with pharmaceutical profits rather than serving the public health.
Flu vaccines are perhaps the most ineffective vaccine on the market. Repeatedly we are told by health officials that the moral argument for its continued use is for “the greater good,” although this imaginary good has never been defined scientifically. For the present 2016 flu season, the CDC has removed Medimmune’s live attenuated flu vaccine (LAIV) FluMist from the market because it was found to be ineffective. Or at least this is the rationale stated by the agency. According to the CDC, one third of children’s influenza vaccinations are with live nasal sprays. Yet regardless of how infective and useless FluMist has been, it has remained on the market since 2003, and in 2014 the CDC recommended it as its flu vaccine of choice for children.
Although last year FluMist was only 3% effective, according to an NBC report, the real truth behind its withdrawal is likely more crucial.  There is no reason to doubt that the vaccine contributed to more cases of flu infection than it prevented. And this is a fundamental flaw with all live vaccines, and even killed attenuated ones, that have been shown to “shed” and infect people in contact with the vaccinated persons, especially those with compromised immune systems.
In her investigative report, “The Emerging Risks of Live Virus and Virus Vectored Vaccines,” Barbara Lo Fisher notes that the attenuated virus in the flu vaccine can shed and infect others for months after vaccination. Both the unvaccinated and the vaccinated are at risk. The CDC acknowledges this risk and warns
“Persons who care for severely immunosuppressed persons who require a protective environment should not receive LAIV, or should avoid contact with such persons for 7 days after receipt, given the theoretical risk for transmission of the live attenuated vaccine virus.”
At their best, flu vaccines remain around 50-60% effective according to official health statements. However, the World Health Organization’s predictions for 2014-2015 flu strains were a bust. The match was such a failure that the CDC was forced to warn the American public that the vaccine was only 23% effective. Given that the 2012-2013 flu season was only 27% effective for the 65 years-plus age group, predictive methodologies to determine which flu strains emerge during any given influenza season have more in common with medieval divination than sound science. For the 1992-1993 and 1997-1998 seasons, the vaccine concoction of flu strains was only 16% effective. Katherine Severyn, who monitors the actual WHO predictions and compares them with CDC claims has stated that, “depending upon the study cited, [flu] vaccine efficacy actually ranges from a low of 0%.
Source: http://www.healthy-holistic-living.com/http://theimprovementclub.com/the-toxic-science-of-flu-vaccines/Health & Fitnessvaccine